Market Cap 564.42M
Revenue (ttm) 292.50M
Net Income (ttm) -33.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -11.62%
Debt to Equity Ratio 0.00
Volume 959,400
Avg Vol 345,608
Day's Range N/A - N/A
Shares Out 41.32M
Stochastic %K 82%
Beta 0.38
Analysts Strong Sell
Price Target $17.00

Company Profile

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy sy...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 518 795 1400
Address:
14 Plaza Drive, Latham, United States
alfredaita
alfredaita Jun. 26 at 6:32 PM
$ANGO been in this for a while CEO hunt still in progress. Maybe they will announce next earnings report? Due this summer.
0 · Reply
N8LongShort
N8LongShort Jun. 26 at 1:45 PM
$ANGO Med Tech Gem Such a well run company - no debt and cash flow can furnish all its future growth No major dilution Tiny Share Float 40M shared outstanding All med tech segments double digit growth yoy Nano Knife game changer for prostate cancer Tam 2B Steve Cohen has 8% stake in this company(feel free to google him) This will be a 100+ stock Insurance coverage expanding recent CPT1 code approval and expanding $XBI $IWM $IHI
0 · Reply
SuperCoach
SuperCoach Jun. 26 at 1:40 PM
$ANGO 70,000 shared in the first 10 minutes of trading. For this one, that’s substantial!!
0 · Reply
N8LongShort
N8LongShort Jun. 25 at 6:31 PM
$ANGO starting to cook and its still not widely known.. holding til 100
0 · Reply
ToadEsquireCapital
ToadEsquireCapital Jun. 25 at 5:37 PM
$ANGO 22.43 EOY 🔮
1 · Reply
Doozio
Doozio Jun. 25 at 2:28 AM
$ANGO ONTO 🐒🍌🧠⏰♾️
0 · Reply
N8LongShort
N8LongShort Jun. 24 at 4:55 PM
$ANGO yall dont listen ive been giving mostly winning tips for days $XBI $IHI $IWM great volume today
0 · Reply
N8LongShort
N8LongShort Jun. 23 at 1:59 PM
0 · Reply
Estimize
Estimize Jun. 18 at 10:04 PM
Wall St is expecting -0.09 EPS for $ANGO Q4 [Reporting 07/21 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c
0 · Reply
prismmarketview
prismmarketview Jun. 18 at 4:34 PM
$ANGO received FDA Investigational Device Exemption approval for its RELIEF feasibility study to evaluate the safety and effectiveness of its NanoKnife irreversible electroporation system. https://prismmarketview.com/companies/angiodynamics-inc/#about
0 · Reply
Latest News on ANGO
AngioDynamics Slides: FY 2026

Jun 10, 2026, 9:20 AM EDT - 16 days ago

AngioDynamics Slides: FY 2026


AngioDynamics announces two-year PRESERVE trial data

2026-05-13T14:48:34.000Z - 6 weeks ago

AngioDynamics announces two-year PRESERVE trial data


AngioDynamics initiated with a Buy at Freedom Broker

2026-04-06T13:46:47.000Z - 2 months ago

AngioDynamics initiated with a Buy at Freedom Broker


AngioDynamics price target lowered to $16 from $18 at Canaccord

2026-04-06T11:01:04.000Z - 2 months ago

AngioDynamics price target lowered to $16 from $18 at Canaccord


AngioDynamics Earnings Call Transcript: Q3 2026

Apr 2, 2026, 8:00 AM EDT - 3 months ago

AngioDynamics Earnings Call Transcript: Q3 2026


AngioDynamics Quarterly report: Q3 2026

Apr 2, 2026, 8:00 AM EDT - 3 months ago

AngioDynamics Quarterly report: Q3 2026


AngioDynamics Earnings release: Q3 2026

Apr 2, 2026, 8:00 AM EDT - 3 months ago

AngioDynamics Earnings release: Q3 2026


AngioDynamics Slides: Q3 2026

Apr 2, 2026, 8:00 AM EDT - 3 months ago

AngioDynamics Slides: Q3 2026


AngioDynamics reports Q3 adjusted EPS (7c), consensus (11c)

2026-04-02T10:07:11.000Z - 3 months ago

AngioDynamics reports Q3 adjusted EPS (7c), consensus (11c)


AngioDynamics Earnings Call Transcript: Q2 2026

Jan 6, 2026, 8:00 AM EST - 6 months ago

AngioDynamics Earnings Call Transcript: Q2 2026


AngioDynamics Quarterly report: Q2 2026

Jan 6, 2026, 8:00 AM EST - 6 months ago

AngioDynamics Quarterly report: Q2 2026


AngioDynamics Earnings release: Q2 2026

Jan 6, 2026, 8:00 AM EST - 6 months ago

AngioDynamics Earnings release: Q2 2026


AngioDynamics Slides: Q2 2026

Jan 6, 2026, 8:00 AM EST - 6 months ago

AngioDynamics Slides: Q2 2026


AngioDynamics reports Q2 adjusted EPS 0c, consensus (10c)

2026-01-06T11:06:04.000Z - 6 months ago

AngioDynamics reports Q2 adjusted EPS 0c, consensus (10c)


AngioDynamics says Jim Clemmer to retire during FY27 as CEO

2026-01-06T11:05:18.000Z - 6 months ago

AngioDynamics says Jim Clemmer to retire during FY27 as CEO


AngioDynamics Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 8:00 AM EST - 8 months ago

AngioDynamics Transcript: UBS Global Healthcare Conference 2025


AngioDynamics management to meet with Lake Street

2025-10-17T15:45:12.000Z - 9 months ago

AngioDynamics management to meet with Lake Street


AngioDynamics price target raised to $18 from $17 at Canaccord

2025-10-03T12:01:47.000Z - 9 months ago

AngioDynamics price target raised to $18 from $17 at Canaccord


AngioDynamics Earnings Call Transcript: Q1 2026

Oct 2, 2025, 8:00 AM EDT - 9 months ago

AngioDynamics Earnings Call Transcript: Q1 2026


AngioDynamics Quarterly report: Q1 2026

Oct 2, 2025, 8:00 AM EDT - 9 months ago

AngioDynamics Quarterly report: Q1 2026


AngioDynamics Earnings release: Q1 2026

Oct 2, 2025, 8:00 AM EDT - 9 months ago

AngioDynamics Earnings release: Q1 2026


AngioDynamics Slides: Q1 2026

Oct 2, 2025, 8:00 AM EDT - 9 months ago

AngioDynamics Slides: Q1 2026


AngioDynamics Proxy statement: Proxy Filing

Sep 25, 2025, 8:00 AM EDT - 9 months ago

AngioDynamics Proxy statement: Proxy Filing


AngioDynamics Proxy statement: Proxy Filing

Sep 25, 2025, 8:00 AM EDT - 9 months ago

AngioDynamics Proxy statement: Proxy Filing


AngioDynamics Earnings Call Transcript: Q4 2025

Jul 15, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Earnings Call Transcript: Q4 2025


AngioDynamics Annual report: Q4 2025

Jul 15, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Annual report: Q4 2025


AngioDynamics Earnings release: Q4 2025

Jul 15, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Earnings release: Q4 2025


AngioDynamics Slides: Q4 2025

Jul 15, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Slides: Q4 2025


AngioDynamics Transcript: Investor Update

Apr 2, 2025, 9:00 AM EDT - 1 year ago

AngioDynamics Transcript: Investor Update


AngioDynamics Slides: Investor Update

Apr 2, 2025, 9:00 AM EDT - 1 year ago

AngioDynamics Slides: Investor Update


AngioDynamics Earnings Call Transcript: Q3 2025

Apr 2, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Earnings Call Transcript: Q3 2025


AngioDynamics Quarterly report: Q3 2025

Apr 2, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Quarterly report: Q3 2025


AngioDynamics Earnings release: Q3 2025

Apr 2, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Earnings release: Q3 2025


AngioDynamics Slides: Q3 2025

Apr 2, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics Slides: Q3 2025


AngioDynamics to Host Virtual Cardiovascular Investor Event

Mar 31, 2025, 8:00 AM EDT - 1 year ago

AngioDynamics to Host Virtual Cardiovascular Investor Event


AngioDynamics Slides: FY 2025

Jan 16, 2025, 10:30 AM EST - 1 year ago

AngioDynamics Slides: FY 2025


AngioDynamics Transcript: Investor Update

Jan 8, 2025, 9:30 AM EST - 1 year ago

AngioDynamics Transcript: Investor Update


AngioDynamics Slides: Investor Update

Jan 8, 2025, 9:30 AM EST - 1 year ago

AngioDynamics Slides: Investor Update


AngioDynamics Earnings Call Transcript: Q2 2025

Jan 8, 2025, 8:00 AM EST - 1 year ago

AngioDynamics Earnings Call Transcript: Q2 2025


AngioDynamics Quarterly report: Q2 2025

Jan 8, 2025, 8:00 AM EST - 1 year ago

AngioDynamics Quarterly report: Q2 2025


AngioDynamics Earnings release: Q2 2025

Jan 8, 2025, 8:00 AM EST - 1 year ago

AngioDynamics Earnings release: Q2 2025


AngioDynamics Slides: Q2 2025

Jan 8, 2025, 8:00 AM EST - 1 year ago

AngioDynamics Slides: Q2 2025


AngioDynamics Earnings Call Transcript: Q1 2025

Oct 3, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Earnings Call Transcript: Q1 2025


AngioDynamics Quarterly report: Q1 2025

Oct 3, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Quarterly report: Q1 2025


AngioDynamics Earnings release: Q1 2025

Oct 3, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Earnings release: Q1 2025


AngioDynamics Slides: Q1 2025

Oct 3, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Slides: Q1 2025


AngioDynamics Proxy statement: Proxy Filing

Sep 26, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Proxy statement: Proxy Filing


AngioDynamics Proxy statement: Proxy Filing

Sep 26, 2024, 8:00 AM EDT - 1 year ago

AngioDynamics Proxy statement: Proxy Filing


AngioDynamics Slides: FY 2024

Aug 13, 2024, 10:00 AM EDT - 2 years ago

AngioDynamics Slides: FY 2024


AngioDynamics to Participate in Upcoming Investor Conferences

Jul 29, 2024, 4:15 PM EDT - 2 years ago

AngioDynamics to Participate in Upcoming Investor Conferences


AngioDynamics Earnings Call Transcript: Q4 2024

Jul 16, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Earnings Call Transcript: Q4 2024


AngioDynamics Annual report: Q4 2024

Jul 16, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Annual report: Q4 2024


AngioDynamics Earnings release: Q4 2024

Jul 16, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Earnings release: Q4 2024


AngioDynamics Slides: Q4 2024

Jul 16, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Slides: Q4 2024


AngioDynamics Earnings Call Transcript: Q3 2024

Apr 4, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Earnings Call Transcript: Q3 2024


AngioDynamics Quarterly report: Q3 2024

Apr 4, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Quarterly report: Q3 2024


AngioDynamics Earnings release: Q3 2024

Apr 4, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Earnings release: Q3 2024


AngioDynamics Slides: Q3 2024

Apr 4, 2024, 8:00 AM EDT - 2 years ago

AngioDynamics Slides: Q3 2024


alfredaita
alfredaita Jun. 26 at 6:32 PM
$ANGO been in this for a while CEO hunt still in progress. Maybe they will announce next earnings report? Due this summer.
0 · Reply
N8LongShort
N8LongShort Jun. 26 at 1:45 PM
$ANGO Med Tech Gem Such a well run company - no debt and cash flow can furnish all its future growth No major dilution Tiny Share Float 40M shared outstanding All med tech segments double digit growth yoy Nano Knife game changer for prostate cancer Tam 2B Steve Cohen has 8% stake in this company(feel free to google him) This will be a 100+ stock Insurance coverage expanding recent CPT1 code approval and expanding $XBI $IWM $IHI
0 · Reply
SuperCoach
SuperCoach Jun. 26 at 1:40 PM
$ANGO 70,000 shared in the first 10 minutes of trading. For this one, that’s substantial!!
0 · Reply
N8LongShort
N8LongShort Jun. 25 at 6:31 PM
$ANGO starting to cook and its still not widely known.. holding til 100
0 · Reply
ToadEsquireCapital
ToadEsquireCapital Jun. 25 at 5:37 PM
$ANGO 22.43 EOY 🔮
1 · Reply
Doozio
Doozio Jun. 25 at 2:28 AM
$ANGO ONTO 🐒🍌🧠⏰♾️
0 · Reply
N8LongShort
N8LongShort Jun. 24 at 4:55 PM
$ANGO yall dont listen ive been giving mostly winning tips for days $XBI $IHI $IWM great volume today
0 · Reply
N8LongShort
N8LongShort Jun. 23 at 1:59 PM
0 · Reply
Estimize
Estimize Jun. 18 at 10:04 PM
Wall St is expecting -0.09 EPS for $ANGO Q4 [Reporting 07/21 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c
0 · Reply
prismmarketview
prismmarketview Jun. 18 at 4:34 PM
$ANGO received FDA Investigational Device Exemption approval for its RELIEF feasibility study to evaluate the safety and effectiveness of its NanoKnife irreversible electroporation system. https://prismmarketview.com/companies/angiodynamics-inc/#about
0 · Reply
alfredaita
alfredaita Jun. 17 at 10:02 PM
$ANGO Still waiting for CEO replacement
0 · Reply
DARKP00L
DARKP00L Jun. 17 at 12:52 PM
$ANGO 08:37 on Jun. 17 2026 AngioDynamics Says FDA Approves IDE Application To Initiate RELIEF Study Evaluating NanoKnife IRE Platform As Minimally Invasive Treatment Option For Men With Benign Prostatic Hyperplasia #tradeideas
0 · Reply
N8LongShort
N8LongShort Jun. 11 at 11:05 AM
$ANGO just google him
0 · Reply
N8LongShort
N8LongShort Jun. 10 at 1:56 PM
$ANGO simplified focus on med tech product lines in last 5 years All segments showing top line yoy growth in double digits Nanoknife TAM 2B with CPT1 Code just recently approved with very high treatment interest for Prostate Cancer Time Magazine named Nanoknife top invention of 2025 Clean Balance Sheet No Debt with cash to fund all future growth Strong future pipeline Steve Cohen increased ownership to 7.7%*trust the billionaires owner of mets* Priced very cheaply compared to future growth HOLD til its SOLD
0 · Reply
N8LongShort
N8LongShort Jun. 10 at 1:45 PM
$ANGO great call today number 1 sleeper pick $XBI $IWM $IHI
0 · Reply
Estimize
Estimize Jun. 10 at 10:03 AM
Wall St is expecting -0.09 EPS for $ANGO Q4 [Reporting 07/21 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c
0 · Reply
Synaptric
Synaptric Jun. 7 at 5:27 PM
$EIG $MHD $ANGO $AIN $DIS The position count of the Cloud Watch universe weakened slightly this week with the three position changes noted above (Tesla, Microsoft, and Disney). This is the third time this year only half of these names have been above-cloud. Free subscription in the link. https://cloudwatch.beehiiv.com/p/retreat-cloud-watch-6-7-2026
0 · Reply
N8LongShort
N8LongShort Jun. 5 at 1:57 PM
0 · Reply
N8LongShort
N8LongShort Jun. 5 at 1:44 PM
$ANGO ive got 13k shares will sell at 100
0 · Reply
SuperCoach
SuperCoach Jun. 4 at 1:28 PM
$ANGO This baby never does a “gap and go.” I’d love to see that this morning. 
0 · Reply
N8LongShort
N8LongShort May. 29 at 2:39 PM
$ANGO https://www.businesswire.com/news/home/20260528366815/en/AngioDynamics-Expands-Patient-Access-to-NanoKnife-IRE-for-Prostate-and-Liver-Cancer-as-Medicare-Coverage-Framework-Takes-Effect $XBI $IHI $IWM
0 · Reply
Estimize
Estimize May. 28 at 10:09 PM
Wall St is expecting -0.09 EPS for $ANGO Q4 [Reporting 07/21 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c
0 · Reply